Supplemental material
Open access
2,409
Views
4
CrossRef citations to date
0
Altmetric
Research Articles
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study
Simina Ticaua Alnylam Pharmaceuticals, Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1096-9627View further author information
Emre Aldinca Alnylam Pharmaceuticals, Cambridge, MA, USA
https://orcid.org/0000-0002-7237-4760View further author information
Michael Polydefkisb Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
https://orcid.org/0000-0002-7584-7447View further author information
David Adamsc Neurology Department, AP-HP, CHU Bicêtre, Université Paris-Saclay, Paris-Saclay, France
https://orcid.org/0000-0002-8722-4108View further author information
Teresa Coelhod Centro Hospitalar Universitário Santo António, European Reference Network – EUroNMD, Porto, PortugalView further author information
, Mitsuharu Uedae Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
https://orcid.org/0000-0002-6814-0582View further author information
Cecilia Halea Alnylam Pharmaceuticals, Cambridge, MA, USAView further author information
, John Vesta Alnylam Pharmaceuticals, Cambridge, MA, USAView further author information
, Paul Nioia Alnylam Pharmaceuticals, Cambridge, MA, USA
https://orcid.org/0000-0002-4804-8148View further author information
Pages 1-11
|
Received 12 Apr 2023, Accepted 27 Jun 2023, Published online: 20 Jul 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.